mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.04 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.04 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.04 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |